Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Penumbra (PEN) PT Raised to $170 at Canaccord Genuity
-
Mistras Group (MG) PT Raised to $17 at Canaccord Genuity
-
HubSpot Inc (HUBS) PT Raised to $210 at Canaccord Genuity
-
Guardant Health (GH) PT Raised to $125 at Canaccord Genuity
-
DLH Holdings (DLHC) PT Lowered to $7 at Canaccord Genuity
-
Cubic (CUB) PT Raised to $74 at Canaccord Genuity
-
AxoGen, Inc. (AXGN) PT Lowered to $30 at Canaccord Genuity
-
Blue Apron (APRN) PT Raised to $8 at Canaccord Genuity
-
Form 8.3 - [accesso Technology Group plc] (CGWL)
-
Canaccord Genuity Group Inc. Reports First Quarter Fiscal 2020 Results
-
Viva Gold Corp Closes Private Placement
-
Aileron Therapeutics Reports Second Quarter 2019 Financial Results
-
vTv Therapeutics to Participate in Upcoming Canaccord Genuity and Solebury Trout Conferences
-
Aptose Reports Results for the Second Quarter Ended June 30, 2019
-
Discovery 2019 Short Duration LP Initial Public Offering – Maximum $25,000,000
-
Everbridge to Present at Upcoming Investor Conferences
-
Teladoc Health to Participate in Upcoming Investor Conferences
-
Teladoc Health to Participate in Upcoming Investor Conferences
-
Vireo Health to Present at the 39th Annual Canaccord Genuity Growth Conference
-
Intra-Cellular Therapies to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Indus Holdings, Inc. to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Palatin Technologies To Present At Canaccord Genuity's 39th Annual Growth Conference
-
inTEST to Present at Canaccord Genuity's 39th Annual Growth Conference
-
Corindus to Present at Canaccord Genuity 39th Annual Growth Conference on August 8, 2019
-
Dynatrace Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
SharpSpring to Present at Canaccord Genuity 39th Annual Growth Conference on August 8, 2019 at 11:00 a.m. ET
-
Pega to Present at Upcoming Investor Conferences
-
ICF to Present at the Canaccord Genuity 39th Annual Growth Conference
-
PAR Technology Corporation to Present at Canaccord Genuity 39th Annual Growth Conference
-
Dolphin Entertainment to Present at the 39th Annual Canaccord Genuity Growth Conference
-
Rezolute Management to Present at 2019 Canaccord Genuity Growth Conference
-
Rezolute Management to Present at 2019 Canaccord Genuity Growth Conference
-
AeroVironment, Inc. to Present at the Canaccord Genuity’s 39th Annual Growth Conference and the Jefferies 2019 Industrials Conference
-
Obalon Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Obalon Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Neovasc to Attend Canaccord Genuity 39th Annual Growth Conference
-
Ayr Strategies to Present at the 39th Annual Canaccord Genuity Growth Conference on August 8, 2019
-
VBI Vaccines to Present at the Canaccord Genuity 39th Annual Growth Conference
-
VBI Vaccines to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Willdan Group to Participate in Canaccord Genuity’s 39th Annual Growth Conference
-
Cresco Labs to Participate in Canaccord Genuity’s 39th Annual Growth Conference
-
Theratechnologies’ CFO to Attend 39ᵗʰ Annual Growth Conference Held by Canaccord Genuity in Boston
-
Theratechnologies’ CFO to Attend 39ᵗʰ Annual Growth Conference Held by Canaccord Genuity in Boston
-
MasTec (MTZ) PT Raised to $66 at Canaccord Genuity
-
HMS Holdings (HMSY) PT Raised to $46 at Canaccord Genuity
-
Fluor (FLR) PT Lowered to $25 at Canaccord Genuity
-
Piedmont Lithium Upcoming Conference Participation
-
POSaBIT Closes Brokered Private Placement
-
Etsy to Participate at Upcoming Investor Conferences
-
Alphatec Holdings, Inc. Announces Closing of Public Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Stock

